Ascension Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bio-Techne
TECH
|
+$963K |
| 2 |
Xylem
XYL
|
+$768K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Financials ETF
VFH
|
+$1.54M |
| 2 |
Emerson Electric
EMR
|
+$1.09M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$315K |
| 4 |
Microsoft
MSFT
|
+$295K |
| 5 |
Honeywell
HON
|
+$283K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 26.48% |
| 2 | Technology | 23.26% |
| 3 | Healthcare | 18.57% |
| 4 | Consumer Staples | 9.78% |
| 5 | Financials | 7.83% |
Similar funds
Ascension Asset Management's Q3 2019 Portfolio in Review
As of Q3 2019, Ascension Asset Management held 74 positions worth $108M, down 4.6% from $113M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ascension Asset Management withdrew a net $8.04M in Q3 2019, closing 4 positions and reducing 59 holdings. Its most notable exit was Vanguard Financials ETF, an estimated $1.54M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Ascension Asset Management opened a new position in Bio-Techne worth $939K.
- Ascension Asset Management's largest Q3 2019 buy was Bio-Techne: 19,200 shares worth $939K.
- Ascension Asset Management's biggest Q3 2019 reduction was Thermo Fisher Scientific, cutting an estimated $315K.
- Ascension Asset Management fully exited Vanguard Financials ETF in Q3 2019, selling an estimated $1.54M.
- Ascension Asset Management's ten largest holdings make up 30% of its $108M portfolio in Q3 2019.
- Ascension Asset Management opened 2 new positions and closed 4 in Q3 2019.
- Ascension Asset Management's portfolio value fell 4.6% quarter-over-quarter to $108M.
Based on Ascension Asset Management's 13F filing for Q3 2019, filed 22 Oct 2019.